AAOS 2022: Opioid-Free Pain Management in Total Hip Arthroplasty .
Opioid-Free Total Hip Arthroplasty: A Prospective, Randomized Controlled Trial
97 patients undergoing total hip arthroplasty were randomized to receive an opioid-free pain management protocol (n=47) or a standard, opioid-based pain management protocol (n=50). The primary outcome of interest was Numeric Rating Scale (NRS) pain scores at 24 hours or discharge. Secondary outcomes of interest included satisfaction with pain control, complications, and the Hip disability and Osteoarthritis Outcome Jr Score (HOOS Jr). Median follow up was 2 months (IQR 1, 11). Pain scores were not significantly different between the two groups at 24 hours. Satisfaction with pain control, HOOS Jr scores, anti-emetic use, and the rate of falls were similar between groups. Constipation occurred more frequently in the opioid-based group. 15% of patients in the opioid-free group required narcotic pain medication.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics